Inflation is in the way and each dollar of ABT asset will double in near future.
That is only the small part of ABT story. ABT nutrition business is poised to grow very high while other part of its business will trend up steadily. ABT has small debt, good cash position and high cash flow. ABT will grow both organically and thru acquisition. Some big investors are aware of above facts while some news media encouraging their investors for quick money in ABBV. ABBV is flying high but look at its debt that ABT unloaded and also time frame for its Humira that will go diown in 3 years. I bet to see ABBV trading 1/3 of ABT by 2015.
I went to Cosco with my wife this week (retired and have the time) and in the pharmacy area I saw almost an entire row of nutrition products starting with baby formula all the way up to older folks and stacked high. All made by ABT. For pharma stocks I prefer the Biotects and own CELG, REGN & SNTS. I sold the ABBV.